AI For Pharma Growth

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by PTC's Technical Specialist, Dimitrije Slavkovic.   He explains how you can improve operational performance with real time data within your organisation using Augmented Reality (AR). AR has become increasingly popular in recent years due to its ability to enhance experiences in various industries such as gaming, education, and re...

In this episode of AI For Pharma Growth, Dr Andree Bates discusses the latest trends in digital transformation and the impact of AI in the pharmaceutical industry.   She explores the difference between digitization and digital transformation and how companies can leverage AI to achieve the latter. Dr Andree Bates discusses the concept of a digital personal assistant and how it can assist both pati...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by David Morgan, the CEO of Zephyr AI, and Jeff Sherman, the co-founder and CTO of Zephyr AI.   They discuss how pharma can use AI to turn disparate clinical data into actionable insights. Despite the rapid advancements in big data and AI, many pharmaceutical companies have not seen a significant change in their approach to researc...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Mike Ryan, Vice President of Eversana.   They discuss the future of pharma and the impact of recent advancements in healthcare. The industry is facing a unique moment, with technology opening up new possibilities for medical interventions and a greater focus on patient outcomes. The combination of artificial intelligence, big da...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr. Pierre Morgon, the Chief Executive Officer of MRGN Advisors, as well as Chairman of the Board of several vaccine companies.    Dr. Morgon discusses the integration of AI in the development of vaccines and its impact on the industry. He highlights the key advantages of using AI in vaccine research and development, including d...

In this episode of AI For Pharma Growth, Dr. Andree Bates is joined by Bertie Odendaal, the Global Head of Transformation for Therapeutic Areas at Boehringer Ingelheim.    They discuss the future of healthcare data, how healthcare spending is likely to evolve over the next few years, and the one space where the future of health will be the most attractive. They explore how AI and data analytics wi...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr. Andrew Rut, Founder and CEO of My Meds and Me, and Dr. John Reeves, CEO and Founder of Conversation Health.   Dr. Rut has experience in safety and business in healthcare, as well as regulatory knowledge from roles in drug discovery and development. Dr. Reeves has expertise in customer and physician/patient experience, and is...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jeffrey Venstrom from GRAIL.   GRAIL takes a new approach to overcome the limitations of individual organ-specific screening tests. They have developed an investigational multi-cancer early detection test that can detect cancer-derived signals in DNA from a single tube of blood.   The earlier that cancer can be found, the higher...

In this episode of AI For Pharma Growth, Dr Andree Bates discusses   some of the issues we have with robotics and consciousness.    Robotics relies heavily on artificial intelligence. Robots use natural language processing, image and object recognition, computational creativity, and deep learning to mimic consciousnesses but they are all AI programming.    Conscious AI and robots will be highly sp...

In this episode of AI For Pharma Growth, Dr Andree Bates explores the ways in which AI is being used in the Pharma Industry.   She also delves into the ethical considerations that come with the use of AI and the ways in which companies are working to ensure that their use of AI is responsible and transparent. Andree gives an overview of the current state of AI and its potential impact on Pharma.  ...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Natalie Yeadon, Co-Founder and CEO of Impetus Digital.    Impetus is focused on helping life science companies have ongoing conversations with their customers through best-in-class online collaboration tools.   Natalie interviews Dr. Andree Bates, who explains how healthcare teams are using artificial intelligence and "future te...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr. Andrew Rut, CEO of My Meds & Me.    They discuss how AI and technology can be used to improve decision making in the world of medicine.   AI in the pharmaceutical world helps doctors and other medical professionals make more informed decisions about the medicines they prescribe. By using machine learning algorithms, doctors...

In this episode of AI For Pharma Growth, Dr Andree Bates explains what pharma’s tough pill to swallow will be.   Dr. Andree Bates, is on a mission to infuse AI and innovation strategy to transform results across the biopharma industry and to turn that into sustainable growth.    Healthcare is changing rapidly, new technologies and techniques have introduced medical interventions and new approaches...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dr John Reeves, CEO and Richard Marcil, COO of Conversation Health.   Conversation Health generates AI-Driven Virtual Experience for Healthcare and Life Sciences. It’s the only platform that is designed specifically for the needs of the pharmaceutical industry using natural language processing and machine learning. There are so...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Alan Crowther who leads the Navlin practice at the company Eversana.     Eversana’s integrated platform combines data and artificial intelligence powered insights to answer pricing and access questions.    In this episode, Alan explains how to use artificial intelligence to make sure that you get your drug price right from the b...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by David Barwick, Senior Director of Capability Development at Amplity Health.   Today’s episode is about how pharma can use artificial intelligence to make learning and development more impactful, personalised and targeted.    All pharma companies have learning and development teams to ensure that the employees are trained and kep...

In this episode of AI For Pharma Growth, Dr Andree Bates is interviewed by Alistair Agnew from Amelia AI. Amelia is much better than a chatbot because Amelia communicates using human-like interactions.    They discuss the benefits of having digital AI colleagues which use conversational AI to perform tasks that don’t explicitly require a human, such as scheduling and customer service.    Conversat...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by  Alan Kalton, Senior Vice President of sales for Aktana and GM of Aktana’s European division & Olivier Aurand, IT Director at Mundipharma.     Aktana is the category creator and leader of intelligent engagement in the global life sciences industry and helps companies strengthen their relationships with healthcare providers to in...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by  Alan Kalton, Senior Vice President of sales for Aktana and GM of Aktana’s European division & Olivier Aurand, IT Director at Mundipharma.   Aktana is the category creator and leader of intelligent engagement in the global life sciences industry and helps companies strengthen their relationships with healthcare providers to insp...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by  Alan Kalton, Senior Vice President of sales for Aktana and GM of Aktana’s European division & Olivier Aurand, IT Director at Mundipharma.   Aktana is the leader of intelligent engagement in the global life sciences industry and helps companies strengthen their relationships with healthcare providers to inspire better patient ca...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Richard Graves, Co-founder & CCO of Sorcero.   Sorcero is an artificial intelligence platform combining machine learning with a powerful natural language understanding engine that is democratising enterprise access to cognitive technology.    Sorcero uses the latest AI advances for frictionless access to trusted answers, knowled...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ariel Evans, CEO of Risk Q and expert in risk management and cybersecurity. Ariel has over 30 years of business and operational leadership; she has built market-defining, data and analytics businesses, and is a thought leader and author in cyber risk, cybersecurity, privacy, and cyber regulation.   Risk Q gives executives the to...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Jeanne Barnett, founder of cysticfibrosis.com.    The non-profit is organised exclusively for charitable, scientific, and educational purposes. More specifically, to provide to the cystic fibrosis community education, learning tools, and access concerning scientific genetic testing, healthcare products, and product information....

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Dima Syrotkin, CEO and Co Founder of Pandatron.   Most people lack the tools and knowledge to develop themselves and their well-being in a structured format. The same is true of companies and their approaches to helping their employees grow and prosper.    By chatting with their Micro-Coaching bot for 30 minutes per week, you ca...

In this episode of AI For Pharma Growth, Dr Andree Bates is joined by Ignacio Medrano, founder of Savana Medica.   Savana develops and applies Artificial Intelligence such as Natural Language Processing, Machine Learning and Deep Learning, to provide real-time access to patient information and clinical documents and converts this data into usable information for healthcare providers investigating...